Cargando…

Thrombopoietin Receptor Agonists: Can These Be the Future Answer to the Deadly Thrombocytopenia in Dengue Fever?

Dengue is considered the most prevalent mosquito-borne viral disease worldwide and sometimes turns out to be life-threatening. Thrombocytopenia is frequently observed in mild and severe cases of dengue. Severe thrombocytopenia, with a platelet count much below the normal range and hemorrhagic manife...

Descripción completa

Detalles Bibliográficos
Autor principal:	Roy, Sayak
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2019
Materias:	Infectious Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550512/ https://www.ncbi.nlm.nih.gov/pubmed/31192066 http://dx.doi.org/10.7759/cureus.4361

Ejemplares similares

Role of Thrombopoietin Receptor Agonists in Inherited Thrombocytopenia
por: Bastida, José María, et al.
Publicado: (2021)

Optimal use of thrombopoietin receptor agonists in immune thrombocytopenia
por: Al-Samkari, Hanny, et al.
Publicado: (2019)

Thrombocytopenia and Procedural Prophylaxis in the Era of Thrombopoietin Receptor Agonists
por: Nilles, Kathy M., et al.
Publicado: (2019)

Use of Thrombopoietin Receptor Agonists in Childhood Immune Thrombocytopenia
por: Garzon, Angelica Maria, et al.
Publicado: (2015)

Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia
por: Shin, Jiwon, et al.
Publicado: (2023)

Evaluating dengue burden in Africa in passive fever surveillance and seroprevalence studies: protocol of field studies of the Dengue Vaccine Initiative
por: Lim, Jacqueline Kyungah, et al.
Publicado: (2018)

Uncovering the Hidden Threat: A Case Report of Suspected Dengue Fever in Armenia
por: Hashmi, Md Foorquan, et al.
Publicado: (2023)

Venovenous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome Due to Severe Fever With Thrombocytopenia Syndrome
por: Fukumoto, Nobu, et al.
Publicado: (2023)

Switching thrombopoietin receptor agonist treatments in patients with primary immune thrombocytopenia
por: González-Porras, José R., et al.
Publicado: (2019)

Thrombopoietin receptor agonist for treatment of immune thrombocytopenia in pregnancy: a narrative review
por: Agarwal, Nikki, et al.
Publicado: (2021)

Prolonged thrombocytopenia after CAR T-cell therapy: the role of thrombopoietin receptor agonists
por: Drillet, Gaëlle, et al.
Publicado: (2022)

Intracerebral Hemorrhage and Thrombocytopenia After AstraZeneca COVID-19 Vaccine: Clinical and Diagnostic Challenges of Vaccine-Induced Thrombotic Thrombocytopenia
por: Wilting, Floor N.H., et al.
Publicado: (2021)

Fighting the Dengue Virus
por: Faraz, Aniqa, et al.
Publicado: (2017)

P1666: EFFECT OF AGONISTS TO THROMBOPOIETIN RECEPTORS ON PLATELET GLYCOME OF PATIENTS WITH IMMUNE THROMBOCYTOPENIA
por: Monzón Manzano, E., et al.
Publicado: (2022)

Thrombopoietin Receptor Agonists for Thrombocytopenia Secondary to HER2-Targeted Antibody Drug Conjugates
por: Rainone, Michael, et al.
Publicado: (2023)

Paying in Blood: A Case of Thrombocytopenia in Covid-19
por: Malik, Jahanzeb, et al.
Publicado: (2020)

Omicron-Induced Immune Thrombocytopenia: A Case Report
por: Toba, Haneen A, et al.
Publicado: (2023)

COVID-19-Induced Thrombocytopenia: A Brief Literature Review and Case Report
por: Nagori, Essam K, et al.
Publicado: (2022)

Successful Treatment with Thrombopoietin Receptor Agonist in Avoiding Splenectomy for Patients with Chronic Refractory Immune Thrombocytopenia
por: Khalafallah, Alhossain, et al.
Publicado: (2012)

Efficacy and safety of thrombopoietin receptor agonists in children with chronic immune thrombocytopenia: a meta-analysis
por: Guo, Jian-Chun, et al.
Publicado: (2017)

Aminotransferases in Relation to the Severity of Dengue: A Systematic Review
por: Kalluru, Pavan Kumar Reddy, et al.
Publicado: (2023)

Hemorrhagic Fever in California
por: Derlet, Robert W., et al.
Publicado: (2000)

Dengue and zika seropositivity, burden, endemicity, and cocirculation antibodies in Nigeria
por: Asaga Mac, Peter, et al.
Publicado: (2023)

Recurrent Fevers in a Triathlete
por: Mangat, Rupinder, et al.
Publicado: (2021)

Current Advance in Thrombopoietin Receptor Agonists in the Management of Thrombocytopenia Associated With Chronic Liver Disease: Focus on Avatrombopag
por: Abdela, Jemal
Publicado: (2019)

Second-line administration of thrombopoietin receptor agonists in immune thrombocytopenia: Italian Delphi-based consensus recommendations
por: Carpenedo, Monica, et al.
Publicado: (2021)

PB2626: THROMBOPOIETIN RECEPTOR AGONISTS FOR RESISTANT THROMBOCYTOPENIA IN PREGNANCY A CASE SERIES AND REVIEW OF LITERATURE
por: Sayed, Gamal, et al.
Publicado: (2023)

Efficacy and safety of thrombopoietin receptor agonists in solid tumors with chemotherapy-induced thrombocytopenia: a meta-analysis
por: Chen, Wen, et al.
Publicado: (2023)

Dengue, Chikungunya, and Zika: The Causes and Threats of Emerging and Re-emerging Arboviral Diseases
por: Soni, Suha, et al.
Publicado: (2023)

Thrombopoietin receptor agonists: ten years later
por: Ghanima, Waleed, et al.
Publicado: (2019)

Effect of Thrombopoietin Receptor Agonist on Pregnant Mice
por: Nakai, Kensaku, et al.
Publicado: (2022)

A Narrative Review of Q Fever in Europe
por: Christodoulou, Magdalini, et al.
Publicado: (2023)

Optimizing SARS-CoV-2 Immunoassays for Specificity in Dengue-Co-Endemic Areas
por: Adnan, Nihad, et al.
Publicado: (2023)

An Unusual Case of Extensively Drug Resistant Typhoid Fever
por: Bhatti, Jamil M, et al.
Publicado: (2019)

Congenital cytomegalovirus infection-related thrombocytopenia
por: Deniz, Melis, et al.
Publicado: (2023)

Cross-sectional study of dengue-related knowledge, attitudes and practices in Villa El Salvador, Lima, Peru
por: Elson, William H, et al.
Publicado: (2020)

The Serological Confirmation and Outcome of the Pediatric Dengue Patients Presenting to Emergency Department: A Cross-Sectional Study
por: Soomar, Sarmad Muhammad, et al.
Publicado: (2022)

Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia
por: Lozano, Maria L., et al.
Publicado: (2019)

Efficacy and safety of thrombopoietin receptor agonists in patients with primary immune thrombocytopenia: A systematic review and meta-analysis
por: Wang, Li, et al.
Publicado: (2016)

Phase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia
por: Jurczak, Wojciech, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_k6it1mdgai4mkjmmrks866ba87